Summit Trail Advisors LLC Decreases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Summit Trail Advisors LLC decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 32.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,044 shares of the exchange traded fund’s stock after selling 7,230 shares during the quarter. Summit Trail Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,395,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. ICA Group Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $27,000. Scarborough Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $32,000. BOCHK Asset Management Ltd purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $36,000. ORG Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at about $40,000. Finally, Vima LLC purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $45,000.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $101.61 on Friday. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The firm has a 50-day moving average of $99.03 and a 200 day moving average of $93.95. The company has a market cap of $7.74 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.